← Leaderboards
Elaine Tierney
Hugo W. Moser Res Inst Kennedy Krieger
$1,338,476
Attributed
$1,338,476
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $276.8K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,338,476 · 7
By mechanism
U54$1,285,881 · 1
M01$52,595 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAutismMental Disorder DiagnosisInstitutionResearch PersonnelResourcesData ManagementFundingPatient /Disease RegistryMedical Outreach /Case FindingMental RetardationAttention Deficit DisorderAsperger SyndromeInterviewNeuropsychological TestsGrantDrug Screening /EvaluationDevelopmental Disease /DisorderHuman Therapy EvaluationComputer Retrieval Of Information On Scientific Projects DatabaseBiomedical FacilityCooperative StudyChild Mental Disorders
Grant awards (11)
CORE--CLINICAL FACILITY$234,604
U54 · FY2007 · MH · contact PI
PULSE AMPLITUDE TESTING (PAT) IN ADOLESCENTS ENDOPAT: A NOVEL TECHNOLOGY$26,050
M01 · FY2007 · RR · contact PI
INVESTIGATION OF SIMVASTATIN THERAPY IN SMITH-LEMI-OPITZ SYNDROME$3,564
M01 · FY2007 · RR · contact PI
CORE--CLINICAL FACILITY$265,037
U54 · FY2006 · MH · contact PI
INVESTIGATION OF SIMVASTATIN THERAPY IN SMITH-LEMI-OPITZ SYNDROME$4,795
M01 · FY2006 · RR · contact PI
CORE--CLINICAL FACILITY$262,808
U54 · FY2005 · MH
INVESTIGATION OF SIMVASTATIN THERAPY IN SMITH-LEMI-OPITZ SYNDROME$13,956
M01 · FY2005 · RR
CORE--CLINICAL FACILITY$258,815
U54 · FY2004 · MH
Methylphenidate in the Treatment of Hyperactivity and Impulsiveness in Children$2,820
M01 · FY2004 · RR
Guanfacine in the Treatment of Children with Pervasive Developmental Disorders$1,410
M01 · FY2004 · RR
CORE--CLINICAL FACILITY$264,617
U54 · FY2003 · MH